An update from the ReIMAGINE Prostate Cancer Risk Study (NCT04060589): A prospective cohort study in men with a suspicion of prostate cancer who are referred onto a magnetic resonance imaging–based diagnostic pathway with donation of tissue, blood, and urine for biomarker analyses
- Publication date
- 1 October 2021
- Publisher
- 'Elsevier BV'